U.S. Senators Baldwin and McCain to President Trump: Hold the Pharmaceutical Industry Accountable for Skyrocketing Prescription Drug Prices
WASHINGTON, D.C. – U.S. Senators Tammy Baldwin (D-WI) and John McCain (R-AZ) today sent a letter to President Trump urging him to hold the pharmaceutical industry accountable and make good on his promise to lower the skyrocketing prescription drug costs that American families are struggling to afford.
“We have offered a simple bipartisan solution that holds the pharmaceutical industry accountable and institutes basic transparency,” the senators continued. “We stand ready to work with you and our colleagues in Congress to address skyrocketing prescription drug prices so that American families can finally be afforded the relief they so desperately need.”
Senators Baldwin and McCain co-authored the FAIR Drug Pricing Act, which would address skyrocketing prescription drug prices and hold pharmaceutical companies accountable by requiring transparency for pharmaceutical corporations that plan to increase drug prices. The bill would not prohibit manufacturers from increasing prices, but it would, for the first time, give taxpayers notice of price increases and bring basic transparency to the market for prescription drugs.
The full letter is available here.
An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin Calls on Trump Administration to Contain Avian Flu, Protect Farmers and Consumers From Price Hikes
Feb 18th, 2025 by U.S. Sen. Tammy Baldwin22.43 million birds affected by avian flu in the last 30 days as prices for consumers hit $8 for a dozen eggs
Senator Baldwin Introduces Bill to Cap Prescription Drug Costs
Feb 14th, 2025 by U.S. Sen. Tammy BaldwinThe Capping Prescription Costs Act would cap annual out-of-pocket prescription drug costs per year at $2,000 for individuals and $4,000 for families
